Paul Gonzales has more than ten years of experience working in oncology drug development. Paul has been with TD2 for six years working with biotech clients and maturing the non-clinical research department. Paul's vast experience in preclinical oncology models contributes to the design and execution of client's preclinical development plans. Paul has aided in the advancement of many of today's oncology treatments at their early development phase. Paul trained in the oncol ogy drug development field at the Cancer Therapy and Research Center. He received his bachelor's degree in Biomedical Sciences from Texas A&M University-College Station.
